Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 12/2018
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

SPOT ON
New medical device regulation: a work of lobbyists

THERAPY FROM A CRITICAL VIEWPOINT
ODYSSEY OUTCOME trial: alirocumab after coronary syndrome
REDUCE-IT trial: protection by fish oil or harm by mineral oil
Stress ulcer prophylaxis with pantoprazole (PANTOZOL, generics): no effect on mortality
Breast cancer: multigene test ONCOTYPE DX for therapeutic decision making
CAR-T cells against cancer?

IN BRIEF
Finally recommendation for lower dosage of colchicine
Vitamin D no protection against cancer and cardiovascular diseases
CANEPHRON against uncomplicated cystitis?
Nitrosamines in sartan drugs the current situation

a-t READERS QUESTIONS AND COMMENTS
Skin cancer with hydrochlorothiazide is xipamide (e.g. XIPAGAMMA) an alternative?  free article 

e a-t ON THE INTERNET
Breast cancer: multigene test ONCOTYPE DX for therapeutic decision making (long version)
CAR-T cells against cancer? (long version)
Valsartan preparations with and without nitrosamine contamination
© 2020 arznei-telegramm